211 related articles for article (PubMed ID: 7752148)
1. The structure of aggrecan and its turnover in cartilage.
Hardingham TE; Fosang AJ
J Rheumatol Suppl; 1995 Feb; 43():86-90. PubMed ID: 7752148
[TBL] [Abstract][Full Text] [Related]
2. The structure, function and turnover of aggrecan, the large aggregating proteoglycan from cartilage.
Hardingham TE; Fosang AJ; Dudhia J
Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):249-57. PubMed ID: 8038265
[TBL] [Abstract][Full Text] [Related]
3. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
4. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of aggrecan.
Kiani C; Chen L; Wu YJ; Yee AJ; Yang BB
Cell Res; 2002 Mar; 12(1):19-32. PubMed ID: 11942407
[TBL] [Abstract][Full Text] [Related]
6. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
[TBL] [Abstract][Full Text] [Related]
7. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
[TBL] [Abstract][Full Text] [Related]
8. Effect of link protein concentration on articular cartilage proteoglycan aggregation.
Tang LH; Buckwalter JA; Rosenberg LC
J Orthop Res; 1996 Mar; 14(2):334-9. PubMed ID: 8648515
[TBL] [Abstract][Full Text] [Related]
9. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
Fosang AJ; Last K; Maciewicz RA
J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
[TBL] [Abstract][Full Text] [Related]
10. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
[TBL] [Abstract][Full Text] [Related]
11. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
Sandy JD; Plaas AH; Koob TJ
Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
[No Abstract] [Full Text] [Related]
12. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
Tortorella MD; Pratta MA; Fox JW; Arner EC
J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
[TBL] [Abstract][Full Text] [Related]
13. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
14. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
15. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation.
Hou WS; Li Z; Büttner FH; Bartnik E; Brömme D
Biol Chem; 2003 Jun; 384(6):891-7. PubMed ID: 12887056
[TBL] [Abstract][Full Text] [Related]
16. Structural differences between two populations of articular cartilage proteoglycan aggregates.
Buckwalter JA; Pita JC; Muller FJ; Nessler J
J Orthop Res; 1994 Jan; 12(1):144-8. PubMed ID: 8113937
[TBL] [Abstract][Full Text] [Related]
17. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
Fosang AJ; Neame PJ; Last K; Hardingham TE; Murphy G; Hamilton JA
J Biol Chem; 1992 Sep; 267(27):19470-4. PubMed ID: 1326552
[TBL] [Abstract][Full Text] [Related]
18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
19. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
Lark MW; Bayne EK; Lohmander LS
Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
[No Abstract] [Full Text] [Related]
20. [Cartilage proteoglycan aggregate: structure and function].
Watanabe H
Clin Calcium; 2004 Jul; 14(7):9-14. PubMed ID: 15577070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
